RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 95 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2016. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $131,000 | +29.7% | 14,567 | -22.7% | 0.00% | – |
| Q2 2016 | $101,000 | +274.1% | 18,845 | +216.7% | 0.00% | – |
| Q1 2016 | $27,000 | +68.8% | 5,951 | +100.0% | 0.00% | – |
| Q4 2015 | $16,000 | -5.9% | 2,975 | +3.7% | 0.00% | – |
| Q3 2015 | $17,000 | -52.8% | 2,870 | +24.1% | 0.00% | – |
| Q2 2015 | $36,000 | +56.5% | 2,313 | +9.7% | 0.00% | – |
| Q1 2015 | $23,000 | +15.0% | 2,109 | +6.6% | 0.00% | – |
| Q4 2014 | $20,000 | +5.3% | 1,979 | 0.0% | 0.00% | – |
| Q3 2014 | $19,000 | -17.4% | 1,979 | 0.0% | 0.00% | – |
| Q2 2014 | $23,000 | +15.0% | 1,979 | 0.0% | 0.00% | – |
| Q1 2014 | $20,000 | -23.1% | 1,979 | 0.0% | 0.00% | – |
| Q4 2013 | $26,000 | -13.3% | 1,979 | 0.0% | 0.00% | – |
| Q3 2013 | $30,000 | +57.9% | 1,979 | 0.0% | 0.00% | – |
| Q2 2013 | $19,000 | – | 1,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |